(18.97.14.80)
[ij] [ij] [ij] 
Email id
 

International Journal of Drug Regulatory Affairs
Year : 2019, Volume : 7, Issue : 3
First page : ( 21) Last page : ( 29)
Print ISSN : 2321-2162. Online ISSN : 2321-6794.
Article DOI : 10.22270/ijdra.v7i3.332

A new drug approval process in Europe: A review

Chakraborty Krishnasis*

Department of Quality Assurance, Al-Ameen College of Pharmacy, Lalbagh Road, Bangalore, India - 560027

*Corresponding author Tel.: +91-9632703191, E-mail address: krishnasis07p@gmail.com (K. Chakraborty)

Online published on 24 May, 2021.

Abstract

Current constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for Marketing Authorization Application (MAA) approval of new drugs. In this present exertion, study expresses the drug approval process and Regulatory requirements according to European Medical Agency (EMA) (1).

Top

Keywords

Drug Approval, Regulatory Requirements, EMA, Marketing Authorization Application (MAA), CHMP, CMS, RMS.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
898,293,595 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.